In comparison, PD patients demonstrated lower DAT reductions (or higher signal) in the caudate head and caudate/putamen transitional region relative to putamen, with smaller posterior putamen-to-caudate binding ratios [107]. The gene discussed is SLC6A3; the disease is Parkinson disease.